Overview Fundamentals API Earnings EOD API Sample Code Pricing

Protagonist Therapeutics Inc (PTGX NASDAQ) stock market data APIs

$35.98 0.43(1.2%) as of July 19, 2024
Price chart is built with Anychart

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Protagonist Therapeutics Inc Financial Data Overview

35.55
35.98
-
36.13
35.41
13.72-38.025
2 085 M
13.9961
58 652 K
315 M
3.26
2.122
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PTGX',
Type: 'Common Stock',
Name: 'Protagonist Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG002B63KM7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1377121',
EmployerIdNumber: '98-0505495',
FiscalYearEnd: 'December',
IPODate: '2016-08-11',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Protagonist Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 315 M
  • EBITDA 150 M
  • Earnings Per Share 2.54
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Protagonist Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast 1.19

Get Protagonist Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com